Results 101 to 110 of about 233,453 (220)

Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi. [PDF]

open access: yes, 2011
OBJECTIVE: To document trends in invasive pneumococcal disease (IPD) in a central hospital in Malawi during the period of national scale-up of antiretroviral therapy (ART) and cotrimoxazole prophylaxis.
Mavuto Mukaka   +41 more
core   +2 more sources

Pneumococcal carriage and disease in adults hospitalised with community-acquired pneumonia in Mongolia: prospective pneumonia surveillance program (2019–2022)

open access: yesPneumonia
Background Streptococcus pneumoniae is an important cause of pneumonia in older adults, however, serotyping and indirect impact information from low and middle-income countries is lacking. Mongolia has a childhood 13-valent pneumococcal conjugate vaccine
Tuya Mungun   +21 more
doaj   +1 more source

Measuring influenza vaccine effectiveness against pneumococcal pneumonia using the screening method

open access: yes, 2017
The aim of this study was to evaluate the feasibility of using the screening method to estimate the influenza vaccine effectiveness against Invasive Pneumococcal Disease (IPD) and Pneumococcal Pneumonia (PP) using hospital and monitoring data.info:eu ...
Nunes, Baltazar   +6 more
core  

Samples for microbiological diagnosis of pneumococcal pneumonia by study period.

open access: yes, 2018
Samples for microbiological diagnosis of pneumococcal pneumonia by study period.
Josep Mensa (3178707)   +9 more
core   +1 more source

Vaccination in Adults with 23 valent Pneumococcal Polysaccharide Vaccine –ABC: Awareness, Benefits and Clinical Aspects

open access: yesGlobal Journal of Medicine and Public Health
Pneumococcus is an important cause of community acquired pneumonia and the commonest cause of community acquired bacterial pneumonia. It also causes invasive pneumococcal disease that increases hospitalization rates, economic burden, morbidity and ...
Salil Bendre   +2 more
doaj   +2 more sources

Efficacy of an 11-Valent Pneumococcal Conjugate Vaccine Against Radiologically Confirmed Pneumonia Among Children Less Than 2 Years of Age in the Philippines A Randomized, Double-Blind, Placebo-Controlled Trial

open access: yes, 2009
Background: Pneumococcus is a leading cause of childhood pneumonia worldwide. Pneumococcal Conjugate vaccines (PCV) have demonstrated efficacy against childhood invasive pneumococcal disease (IPD) and pneumonia in the United States and Africa.
Sombrero, Lydia   +37 more
core   +1 more source

PNEUMOCOCCAL INFECTIONS AND VACCINATION — CAN PREVENTION REDUCE THE BURDEN OF THE ILLNESS

open access: yesПедиатрическая фармакология, 2007
The article gives the findings of the widest ranging research carried on in the USA to appraise the efficiency of vaccination by the study of the hospitalization frequency for pneumonia of any etiology and for dehydration after the program of ...
L.S. Namazova   +2 more
doaj   +2 more sources

Serum concentrations of pneumococcal anticapsular antibodies in children with pneumonia associated with Streptococcus pneumonia infection

open access: yes, 2003
The levels of specific IgG antibody to pneumococcal capsular polysaccharides were investigated in 182 children, aged 2-5 years, who were hospitalized for community-acquired pneumonia, including 55 (30.2%) with evidence of acute pneumococcal infection ...
A. Lastrico   +8 more
core   +1 more source

Age-stratified incidence (per 100,000 persons per year) and case-fatality rate of invasive pneumococcal disease (IPD), pneumococcal pneumonia (PP) and community-acquired pneumonia (CAP).

open access: yes, 2018
Age-stratified incidence (per 100,000 persons per year) and case-fatality rate of invasive pneumococcal disease (IPD), pneumococcal pneumonia (PP) and community-acquired pneumonia (CAP).
Saem Na Lee (5040260)   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy